Setolabo LLC’s next-generation cancer testing technology using miRNA and AI was featured on the Japan Broadcasting Corporation (NHK)!
This episode also covers research into the practical application of genetic analysis technology aimed at ultra-early cancer detection,
as well as the company’s selection as a J-Startup WEST participant that supports this research, and government support through the Go-Tech program.
▼ Click here for the program article
🔗 NHK Takamatsu | Broadcast on February 17, 2025
We aim to realize a future where 16 types of cancer can be detected simultaneously with a single blood draw,
and we work on research and development every day in collaboration with Kagawa University School of Medicine and medical institutions.
We are very honored that our activities have become widely known in this way,
and we will continue to work with even greater responsibility and passion to implement technologies that advance the possibilities of medicine.
We would like to express our sincere gratitude to everyone who supports us.